ScripRevolution Medicines has strengthened its chances of becoming a leader in KRAS-targeting drugs with new Phase I results from zoldonrasib in non-small cell lung cancer (NSCLC). Analysts think the new m
ScripThe heads of two of Europe’s pharma powerhouses have urged the EU to increase drug prices towards levels paid in the US, a move which is unlikely to be greeted with enthusiasm on the cash-strapped con
Pink SheetThe heads of two of Europe’s largest pharma companies urged the EU to increase drug prices to be more in line with the US, a move unlikely to be greeted enthusiastically in the cash-strapped continent
Pink SheetThe Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices sprinted through a condensed two-day schedule at its 15-16 April meeting, which originally had been planne